A 90-minute COVID-19 test has been shown to have over 94 per cent sensitivity, and 100 per cent specificity in a new study. The work, published in the journal The Lancet Microbe, was ledby scientists ...
As the COVID-19 pandemic continues to ravage countries across the globe, screening has become a necessary weapon for fighting the epidemic. Currently utilized testing methods, however, require ...
MADISON, Wis., Oct. 22, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the pivotal ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
In a guidance document issued by the Association for Diagnostics & Laboratory Medicine, updated recommendations are presented ...
The Theraflu Home FluTest, a novel rapid influenza diagnostic test, demonstrated good sensitivity and specificity for both influenza A and B viruses. This article is part of Pulmonology Advisor’s ...
Medical tests, like the blood tests that look for antibodies to the novel coronavirus, aren't perfect. Sometimes, you end up with a false negative: You actually did have the coronavirus and your ...
ST. LOUIS, Jan. 10, 2023 /PRNewswire/ -- Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced favorable results from the ...
Dana-Farber Cancer Institute researchers report the development of a new blood test that has shown the ability in a multi-center trial to screen for numerous types of cancer with a high degree of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback